...
首页> 外文期刊>Colloids and Surfaces, B. Biointerfaces >Preparation and in vitro/in vivo evaluation of doxorubicin-loaded poly [lactic-co-glycol acid] microspheres using electrospray method for sustained drug delivery and potential intratumoral injection
【24h】

Preparation and in vitro/in vivo evaluation of doxorubicin-loaded poly [lactic-co-glycol acid] microspheres using electrospray method for sustained drug delivery and potential intratumoral injection

机译:用电喷雾方法制备和体内/体内评价多柔比蛋白加载的多辛蛋白加载的聚[乳酸二乙二醇酸]微球,用于持续的药物递送和潜在的腹腔内注射

获取原文
获取原文并翻译 | 示例

摘要

For cancer treatment, intratumoral drug injection has many limitations and not commonly adopted. The poly [lactic-co-glycolic acid] (PLGA) has emerged as a promising vehicle to enhance the in vitro/in vivo characteristic of various drugs. We prepared doxorubicin-PLGA microspheres (DOX-PLGA MSs) using the electrospray method. An in vitro elution method was employed to evaluate the release of DOX from the MSs. We performed an in vivo study on rats, in which we directly injected DOX-PLGA MSs into the liver. We measured liver and plasma DOX concentrations to assess local retention and systemic exposure. The mean diameter of the MSs was 6.74 +/- 1.01 mu m. The in vitro DOX release from the MSs exhibited a 12.3 % burst release on day 1, and 85.8 % of the drug had been released after 30 days. The in vivo tests revealed a higher local drug concentration at the target lobe of the liver than at the adjacent median lobe. In the first week, the DOX concentration in the peripheral blood of the MS group was lower than that of the direct DOX injection group. Based on the measured intrahepatic concentration and plasma pharmacokinetic profiles, DOX-PLGA MSs could be suitable vectors of chemotoxic agents for intratumoral injection.
机译:对于癌症治疗,肿瘤内注射注射有许多局限性,并且不常用。聚[乳酸 - 共乙醇酸](PLGA)作为有希望的载体,以增强各种药物的体外/体内特征。我们使用电喷雾方法制备了Doxorubicin-PLGA微球(DOX-PLGA MSS)。使用体外洗脱方法评估来自MSS的DOX的释放。我们对大鼠进行了体内研究,其中我们将DOX-PLGA MSS直接注入肝脏。我们测量肝脏和血浆DOX浓度,以评估局部保留和全身暴露。 MS的平均直径为6.74 +/- 1.01 mu m。来自MSS的体外Dox释放在第1天显示12.3%的爆发释放,85.8%的药物在30天后被释放。体内测试显示肝脏靶叶的局部药物浓度高于相邻的中值叶。在第一周,MS组外周血中的DOX浓度低于直接DOX注射组的血液。基于测量的肝内浓度和血浆药代动力学曲线,DOX-PLGA MSS可以是妥灭毒剂的合适载体载体。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号